News

Congratulations! TransThera's Class 1 Innovative Drug Jienengtai® Approved for Marketing, with Taimei Technology's Digital and Intelligent Solutions Supporting the Entire Process

Taimei Technology Appears at 2026 Frost & Sullivan Summit, Elaborating on "AI for Success" Philosophy

AI Drug Discovery Enters the Second Half: Clinical Development Capabilities Become Key to Commercial Value Realization

Congratulations! Haisco's Suprasibopan Succinate Tablets Approved for Marketing, Taimei Technology's Digital and Intelligent Solutions Empower Pharmaceutical Innovation

Congratulations! Trinomab Debuts on SSE STAR Market, Taimei Technology Powers Digital-Intelligent Marketing

Deepening Global Clinical Research Collaboration: Taimei Technology Experts Visit Top Japanese Medical Institutions

Breaking Through the "Valley of Death" in Drug R&D with AI: Monograph by Dr. Chen Jie, CSO of Taimei Technology, Released Globally

Successfully Delivered! Taimei Technology's eSafety Supports GreenLight Clinical in Building Global Pharmacovigilance Capabilities

ICH M11 Reshapes Global Clinical Development, Taimei Technology's AI Platform Value Accelerates Release